EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY-NC-ND 4.0

Low testosterone levels in men at age 31 associates with future risk of prediabetes and type 2 diabetes: A birth cohort study

Tuomisto A, Pinola P, Pesonen P, Franks S, Martikainen H, Tapanainen Js, Niinimäki M, Morin-Papunen L

Andrology · 2026-07 · 14 (5) · 1209-1219

DOI: 10.1111/andr.70122 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Andrology, online erschienen am 16.09.2025. Verfasst von Tuomisto A und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Oulu University Hospital, Wellbeing Services County of North Ostrobothnia, Oulu, Finland. Hauptthemen laut MEDLINE: Prediabetic State, Diabetes Mellitus, Type 2, Testosterone. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Oulu University Hospital, the Ministry of Health and Social Affairs, National Institute for Health and Welfare.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

We aimed to investigate the association of a low serum testosterone concentration with the risk of abnormal glucose metabolism (i.e., prediabetes and type 2 diabetes) in men at a 15‐year follow‐up. Study population and methods In a population birth cohort, men with low testosterone (testosterone < 12.1 nmol/L, n = 136) and normal testosterone concentration (testosterone ≥ 12.1 nmol/L, n = 2555) at age 31 were followed up until age 46. Blood samples were drawn at ages 31 and 46, and an oral glucose tolerance test ( n = 1409) was performed at age 46.

Results

Men with low testosterone had significantly greater body mass index and waist circumference than men with normal testosterone at ages 31 and 46 ( p < 0.001 in all comparisons). In men with low testosterone, the association with abnormal glucose metabolism was mainly driven by adiposity ( p = 0.4 after adjusting for waist circumference). However, the risk remained increased, independently of waist circumference, when comparing the lowest and highest quartiles of testosterone (odds ratio:1.8 [95% confidence interval 1.3–2.7]) or when using testosterone as a continuous variable (odds ratio: 0.97 [95% confidence interval 0.95–0.99]). Between ages 31 and 46, body mass index increased more in men with normal testosterone at age 31 and low testosterone at age 46 than in men with normal testosterone or low testosterone at both ages ( p < 0.001). Higher sex hormone binding globulin levels were associated with a lower risk for abnormal glucose metabolism independently of waist circumference ( p < 0.001).

Conclusion

Low levels of testosterone and sex hormone binding globulin at age 31 associated with an increased risk of developing abnormal glucose metabolism after 15 years’ follow‐up. This association was partly independent of adiposity but was linked to waist circumference and weight gain.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prediabetic StateDiabetes Mellitus, Type 2TestosteroneHumansMaleAdultMiddle AgedWaist CircumferenceRisk FactorsBody Mass IndexGlucose Tolerance TestCohort StudiesBlood GlucoseAdipositySex Hormone-Binding Globulin

Stichwörter der Autor:innen

abnormal glucose metabolismlow testosteronemaleprediabetestype 2 diabetes

Substanzen

TestosteroneBlood GlucoseSex Hormone-Binding Globulin

Autor:innen und Institutionen

  • Department of Obstetrics and Gynecology, Oulu University Hospital, Wellbeing Services County of North Ostrobothnia, Oulu, Finland.
  • Medical Research Center, Research Unit of Clinical Medicine, University of Oulu, Oulu, Finland.
  • Institute of Reproductive and Developmental Biology, Imperial College London, London, UK.
  • Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.

Förderung

  • Oulu University Hospital
  • the Ministry of Health and Social Affairs
  • National Institute for Health and Welfare
  • Regional Institute of Occupational Health
  • Terveyden ja hyvinvoinnin laitos
  • ERDF European Regional Development Fund
  • Regional Institute of Occupational Health, Oulu, Finland
  • Sosiaali- ja Terveysministeriö

Zitieren

APA

A, T., P, P., P, P., S, F., H, M., Js, T., M, N., & L, M. P. (2026). Low testosterone levels in men at age 31 associates with future risk of prediabetes and type 2 diabetes: A birth cohort study. Andrology, 14(5), 1209-1219. https://doi.org/10.1111/andr.70122

Vancouver

A T, P P, P P, S F, H M, Js T, et al. Low testosterone levels in men at age 31 associates with future risk of prediabetes and type 2 diabetes: A birth cohort study. Andrology. 2026;14(5):1209-1219. doi:10.1111/andr.70122

BibTeX
@article{A2026,
  author = {A, Tuomisto and P, Pinola and P, Pesonen and S, Franks and H, Martikainen and Js, Tapanainen and M, Niinimäki and L, Morin-Papunen},
  title = {Low testosterone levels in men at age 31 associates with future risk of prediabetes and type 2 diabetes: A birth cohort study},
  journal = {Andrology},
  year = {2026},
  volume = {14},
  number = {5},
  pages = {1209--1219},
  doi = {10.1111/andr.70122}
}
Kostenlos starten →